BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ARMI - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.armiusa.org
X-WR-CALDESC:Events for ARMI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260706
DTEND;VALUE=DATE:20260709
DTSTAMP:20260613T055210
CREATED:20260529T013621Z
LAST-MODIFIED:20260529T013738Z
UID:10001802-1783296000-1783555199@www.armiusa.org
SUMMARY:Cell & Gene Therapy Summit 2026
DESCRIPTION:Advancing the Path from Innovation to Commercially Viable Therapies\nThe Cell & Gene Therapy Summit 2026 brings together leaders from industry\, academia\, healthcare\, and government to discuss the latest advancements in cell and gene therapy development\, manufacturing\, commercialization\, and patient access. \nThis year’s summit focuses on advancing cell and gene therapies through innovation\, technology\, and collaboration\, covering topics ranging from manufacturing and process development to regulatory strategy\, commercialization\, and market adoption. The event convenes experts across the therapeutic development lifecycle to address the challenges and opportunities shaping the future of advanced therapies. \nJennifer MacDonald\, Chief Operating Officer of ARMI\, will serve as a panelist during the session\, “Creating a Commercially Viable Therapy.” The discussion will examine the critical factors required to successfully translate promising therapies from research and clinical development into scalable\, commercially sustainable products capable of reaching patients. \nARMI’s participation reflects its commitment to advancing manufacturing innovation\, strengthening supply chains\, and addressing the practical challenges associated with scaling regenerative medicine and advanced therapy products. \nJoin leaders from across the cell and gene therapy community in Boston for three days of technical presentations\, industry insights\, networking\, and collaboration. \n 
URL:https://www.armiusa.org/event/cell-gene-therapy-summit-2026/
LOCATION:Four Points by Sheraton Wakefield Boston Hotel & Conference Center\, One Audubon Rd\, Wakefield\, MA\, 01880\, United States
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260708
DTEND;VALUE=DATE:20260712
DTSTAMP:20260613T055210
CREATED:20260529T014126Z
LAST-MODIFIED:20260529T094606Z
UID:10001803-1783468800-1783814399@www.armiusa.org
SUMMARY:ISSCR 2026 Annual Meeting
DESCRIPTION:Exploring the Latest Advances in Stem Cell Research and Regenerative Medicine\nThe ISSCR 2026 Annual Meeting brings together nearly 3\,500 scientists\, clinicians\, industry leaders\, and innovators from around the world to share the latest discoveries in stem cell research and regenerative medicine. \nRecognized as the leading international event for the stem cell community\, ISSCR provides a forum for scientific exchange\, collaboration\, and discussion across a broad range of topics\, including clinical applications\, disease modeling and drug discovery\, engineering biology\, ethics and policy\, and somatic stem cell research. \nARMI will attend ISSCR 2026 to engage with researchers\, clinicians\, industry partners\, and innovators advancing the science and translation of regenerative medicine. The meeting offers an opportunity to explore emerging technologies\, strengthen collaborations\, and gain insights into the scientific advancements that will shape the future of advanced therapies and their path to commercialization. \nJoin the global stem cell community in Montréal for four days of groundbreaking science\, networking\, and collaboration.
URL:https://www.armiusa.org/event/isscr-2026-annual-meeting/
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261008
DTSTAMP:20260613T055210
CREATED:20260529T091438Z
LAST-MODIFIED:20260529T094526Z
UID:10001805-1791158400-1791417599@www.armiusa.org
SUMMARY:Cell & Gene Meeting on the Mesa 2026
DESCRIPTION:Advancing the Commercialization of Cell and Gene Therapies\nThe Cell & Gene Meeting on the Mesa is one of the premier annual conferences dedicated to advancing the commercialization of cell and gene therapies. Bringing together more than 1\,500 industry leaders\, investors\, technology developers\, manufacturers\, and healthcare innovators\, the event serves as a critical forum for addressing the challenges and opportunities shaping the future of advanced therapies. \nThe conference explores key topics including clinical development\, manufacturing scale-up\, supply chain readiness\, regulatory strategy\, reimbursement models\, investment trends\, and commercialization pathways. Through expert-led panels\, company presentations\, partnering meetings\, and networking opportunities\, attendees gain insights into the technologies and business models driving the next generation of therapies. \nARMI will attend Meeting on the Mesa 2026 to engage with leaders across the cell and gene therapy community\, strengthen strategic partnerships\, and participate in discussions focused on translating scientific innovation into scalable\, commercially viable products. The event aligns closely with ARMI’s mission to accelerate the development and manufacturing of regenerative medicine technologies while strengthening domestic biomanufacturing capabilities. \nJoin industry leaders in Phoenix for three days of collaboration\, networking\, and discussion focused on bringing advanced therapies from development to widespread patient impact.
URL:https://www.armiusa.org/event/cell-gene-meeting-on-the-mesa-2026/
LOCATION:Arizona Biltmore\, 2400 E Missouri Ave\, Phoenix\, AZ\, 85016\, United States
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/Featuredinperson-e1653358665154.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261115
DTEND;VALUE=DATE:20261119
DTSTAMP:20260613T055210
CREATED:20260529T093412Z
LAST-MODIFIED:20260529T093412Z
UID:10001806-1794700800-1795046399@www.armiusa.org
SUMMARY:TERMIS-AM 2026
DESCRIPTION:Connecting Research\, Translation\, and Manufacturing in Regenerative Medicine\nThe Tissue Engineering and Regenerative Medicine International Society – Americas (TERMIS-AM) 2026 Conference brings together leading researchers\, clinicians\, industry innovators\, and technology developers to explore the latest advances in tissue engineering\, regenerative medicine\, and advanced therapies. \nCelebrating the 20th anniversary of TERMIS\, the 2026 conference will focus on the theme “Bench. Chip. Clinic. Where Y’at in Regeneration?” and highlight emerging technologies that are accelerating the translation of scientific discoveries into clinical applications. Featured topics include CRISPR and lipid nanoparticles\, organ-on-chip models\, artificial intelligence\, biomaterials\, cell therapies\, and regenerative medicine innovations. \nARMI plans to participate in TERMIS-AM 2026 to engage with the global regenerative medicine community\, strengthen collaborations\, and explore scientific and manufacturing advances that support the development\, scale-up\, and deployment of next-generation therapies. The conference provides a valuable opportunity to connect research\, technology development\, manufacturing\, and clinical translation across the regenerative medicine landscape. \nJoin leaders from academia\, industry\, healthcare\, and government in New Orleans for four days of scientific discovery\, networking\, and collaboration focused on advancing the future of regenerative medicine.
URL:https://www.armiusa.org/event/termis-am-2026/
LOCATION:New Orleans\, Louisiana
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
END:VCALENDAR